What is the current Drug-Coated Balloons market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Drug-Coated Balloons market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Drug-Coated Balloons market?

Increasing demand for minimally invasive procedures drives the market.

What are the major challenges facing the Drug-Coated Balloons market?

Stringent regulatory requirements pose a significant challenge.

Which regions are leading the Drug-Coated Balloons market?

North America and Europe are the leading regional markets.

Who are the top companies in the Drug-Coated Balloons market?

Medtronic and Boston Scientific are among the top market players.

What future opportunities exist in the Drug-Coated Balloons market?

Emerging markets and technological advancements offer growth opportunities.

How does technology impact the Drug-Coated Balloons market?

Advances in balloon design and coating technology enhance market growth.

What is the current regulatory landscape for the Drug-Coated Balloons market?

Regulations vary by region, with the FDA and CE marking key approvals.

How will the Drug-Coated Balloons market size change in the next 5 years?

The market is expected to reach USD 2.5 billion by 2028.

Drug-Coated Balloons Market Comprehensive Report: 200+ Pages | 2026–2034

Drug-Coated Balloons by Application (Hospitals, Cardiac Catheterization Labs, ASCs), by Types (DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Drug-Coated Balloons Market Overview

The Drug-Coated Balloons market refers to the industry involved in the development and distribution of balloons coated with drugs, used for minimally invasive procedures to treat vascular diseases. The relevance of this market lies in its potential to provide effective treatment options for patients with vascular diseases. As of 2025, the current Drug-Coated Balloons market size is approximately $1.3 billion. The growth outlook for the Drug-Coated Balloons market is promising, with a market forecast that indicates a significant increase in demand over the next few years, driven by the industry expansion of minimally invasive procedures and the growing prevalence of vascular diseases. The scope of this market encompasses various types of drug-coated balloons, including paclitaxel-coated and sirolimus-coated balloons, used in applications such as peripheral artery disease and coronary artery disease.

Loading chart…

The growth forecast for the Drug-Coated Balloons market indicates a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of vascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Key forces shaping the industry include technology shifts towards more advanced and effective drug-coated balloons, regulations governing the approval and use of these devices, and competitive intensity among market players. The largest region in the Drug-Coated Balloons market is North America, while the fastest-growing region is Asia-Pacific, driven by the growing healthcare infrastructure and increasing adoption of minimally invasive procedures in these regions.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	7.13 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; B. Braun Melsungen; Koninklijke Philips; Boston Scientific; Opto Circuits (India); Acotec Scientific; AR Baltic Medical; Acrostak; Biosensors International Group; BioMed; Concept Medical; Cardionovum; Endocor; Hexacath Sverige; iVascular SLU; Minvasys; MedAlliance; QT Vascular; RD Global-Invamed; SurModics; Terumo; Wellinq
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Drug-Coated Balloons market is poised for significant growth, driven by increasing demand for minimally invasive procedures and advancements in technology. The growth forecast for the market is promising, with the Drug-Coated Balloons market size expected to expand substantially over the next few years.

Growth Drivers2 items

Increasing prevalence of peripheral artery disease and other vascular conditions is driving demand for Drug-Coated Balloons, which offer a minimally invasive treatment option with reduced risk of complications

Advances in balloon technology, such as improved drug coating and delivery mechanisms, are enhancing the efficacy and safety of Drug-Coated Balloons, contributing to their growing adoption

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Drug-Coated Balloons market, which may hinder market growth

The Drug-Coated Balloons market is experiencing pricing pressure due to competition from alternative treatment options, such as bare-metal stents and angioplasty, which may impact revenue growth

Opportunities2 items

Emerging markets, such as Asia Pacific and Latin America, offer significant growth opportunities for Drug-Coated Balloons due to increasing healthcare expenditure and improving healthcare infrastructure

The development of Drug-Coated Balloons for new indications, such as coronary artery disease, is expected to further drive market growth and expand the patient base

Challenges2 items

The Drug-Coated Balloons market is experiencing challenges related to device trackability and reimbursement, which may impact adoption rates and revenue growth

The lack of standardization in Drug-Coated Balloons design and manufacturing processes may lead to variability in product quality, affecting patient outcomes and market credibility

Market Segmentation

Loading chart…

The Application segment in the Drug-Coated Balloons market refers to the various medical conditions and procedures where these balloons are utilized. This includes peripheral artery disease, coronary artery disease, and other vascular diseases. Understanding the application segmentation is crucial for Drug-Coated Balloons segmentation as it helps in identifying the target audience and developing strategies to cater to their specific needs. The application segment contributes significantly to the overall market size, with different applications having varying levels of demand and growth prospects.

The Types segment in the Drug-Coated Balloons market encompasses various subtypes, such as [object Object] and [object Object]. Each subtype has its unique characteristics, advantages, and limitations. Analyzing the types segment is essential for understanding the market taxonomy of Drug-Coated Balloons, as it enables manufacturers to design and develop products that meet specific customer requirements. The types segment plays a vital role in determining the overall market size, with different types experiencing distinct growth trajectories and market trends.

Drug-Coated Balloons Segmentation Breakdown8 items

Application

Hospitals

Cardiac Catheterization Labs

ASCs

Types

DCB for Peripheral Artery Disease

DCB for Coronary Artery Disease

DCB for Other Indications

Regional Insights

Loading chart…

The Drug-Coated Balloons market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of minimally invasive procedures, favorable policies and investments in healthcare infrastructure, and a rapidly growing demographics with a high prevalence of cardiovascular diseases.

In North America, the market is driven by factors such as high ecosystem maturity, widespread adoption of advanced medical technologies, and a strong infrastructure for healthcare services. Europe is driven by factors such as favorable policies and investments in healthcare, a high demographics with a significant prevalence of cardiovascular diseases, and a well-established infrastructure for medical research and development. Latin America and Middle East & Africa are driven by factors such as increasing adoption of minimally invasive procedures, growing investments in healthcare infrastructure, and a rapidly growing demographics with a high prevalence of cardiovascular diseases.

Regional Drivers4 items

Asia Pacific: increasing adoption, favorable policies and investments, growing demographics

North America: high ecosystem maturity, widespread adoption, strong infrastructure

Europe: favorable policies and investments, high demographics, well-established infrastructure

Latin America and Middle East & Africa: increasing adoption, growing investments, rapidly growing demographics

Competitive Landscape

The Drug-Coated Balloons market is moderately consolidated, driven by a mix of global players and local/regional companies. The Drug-Coated Balloons competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and distribution networks, while local companies concentrate on pricing and regional partnerships.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to changing market conditions and regulatory requirements.

Medtronic: regional expansion

BD: premium pricing

B. Braun Melsungen: innovation pipeline

Koninklijke Philips: local manufacturing

Boston Scientific: OEM tie-ups

Opto Circuits (India): vertical integration

Key Drug-Coated Balloons Companies23 items

Medtronic

B. Braun Melsungen

Koninklijke Philips

Boston Scientific

Opto Circuits (India)

Acotec Scientific

AR Baltic Medical

Acrostak

Biosensors International Group

BioMed

Concept Medical

Cardionovum

Endocor

Hexacath Sverige

iVascular SLU

Minvasys

MedAlliance

QT Vascular

RD Global-Invamed

SurModics

Terumo

Wellinq

Market Ecosystem

The Drug-Coated Balloons ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly categorized into three segments: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and used. The value chain analysis of the Drug-Coated Balloons ecosystem reveals how value is created and captured at each stage, from research and development to commercialization and patient care.

Raw material/component suppliers — providing essential materials

OEMs / manufacturers — designing and producing Drug-Coated Balloons

Technology providers — developing underlying technologies

System integrators / EPCs — integrating products into medical systems

Distributors / channel partners — delivering products to healthcare providers

Regulators/standards bodies — establishing and enforcing industry standards

End users / buyers — healthcare providers and patients using the products

The flow of value through the Drug-Coated Balloons ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can also impact the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can affect the ability of participants to adapt to changes in the ecosystem. The ecosystem's dynamics can differ by region, with varying regulatory frameworks and market conditions influencing the adoption and use of Drug-Coated Balloons.

Recent Industry Insights

The Drug-Coated Balloons industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Cardinal Health, have focused on expanding product portfolios and enhancing distribution networks. Additionally, there have been notable mergers and acquisitions, including the acquisition of Surmodics by Abbott, which aim to strengthen market positions and drive innovation.

Furthermore, the industry has seen the launch of new products and technologies, such as next-generation drug-coated balloons with improved efficacy and safety profiles. Regulatory changes, including the updated guidelines for clinical trials, have also impacted the market. Shifts in consumer and enterprise trends, including the increasing adoption of minimally invasive procedures, have driven demand for drug-coated balloons. Funding rounds and expansions have also been observed, with companies like Becton Dickinson investing in research and development to stay ahead in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Drug-Coated Balloons market. The market attractiveness is moderate, driven by increasing demand for minimally invasive treatments and a growing patient population. The competitive intensity is high, with key players investing heavily in research and development to improve product efficacy and safety. The long-term outlook for the Drug-Coated Balloons market outlook is positive, with opportunities for growth in emerging markets and expanding applications.

The innovation landscape is characterized by advancements in balloon technology, coating materials, and delivery systems. However, the demand-supply balance may be affected by regulatory hurdles, reimbursement challenges, and supply chain disruptions. Key risk factors include intense competition, stringent regulatory requirements, and potential product recalls. Overall, our analysis highlights the need for strategic planning, investment in innovation, and proactive risk management to succeed in this dynamic market.

11 items

1. Executive Summary

2. Drug-Coated Balloons Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Drug-Coated Balloons Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Drug-Coated Balloons Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Cardiac Catheterization Labs

6.1.3. ASCs

6.2. Global Drug-Coated Balloons Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DCB for Peripheral Artery Disease

6.2.2. DCB for Coronary Artery Disease

6.2.3. DCB for Other Indications

6.3. Global Drug-Coated Balloons Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Drug-Coated Balloons Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Drug-Coated Balloons Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Drug-Coated Balloons Market Competition by Key Manufacturers

8.1. Global Drug-Coated Balloons Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Drug-Coated Balloons: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun Melsungen

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Koninklijke Philips

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Boston Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Opto Circuits (India)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Acotec Scientific

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. AR Baltic Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Acrostak

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Biosensors International Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BioMed

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Concept Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cardionovum

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Endocor

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hexacath Sverige

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. iVascular SLU

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Minvasys

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. MedAlliance

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. QT Vascular

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. RD Global-Invamed

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. SurModics

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Terumo

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Wellinq

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Drug-Coated Balloons Market

Figure 4: Global Drug-Coated Balloons Market: Drivers

Figure 5: Global Drug-Coated Balloons Market: Challenges

Figure 6: Global Drug-Coated Balloons Market: Trends

Figure 7: Global Drug-Coated Balloons Market: Opportunity

Figure 8: Global Drug-Coated Balloons Market: Restraint

Figure 9: Global Drug-Coated Balloons Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Drug-Coated Balloons Market Value (USD Million) By Region

Figure 15: Global Drug-Coated Balloons Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Drug-Coated Balloons Market Value (USD Million) By Region

Figure 23: Global Drug-Coated Balloons Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global Drug-Coated Balloons Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Drug-Coated Balloons Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Drug-Coated Balloons Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Drug-Coated Balloons Market Value (USD Million) By Region

Table 10: Global Drug-Coated Balloons Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Drug-Coated Balloons Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Drug-Coated Balloons Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Drug-Coated Balloons Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: B. Braun Melsungen Basic Information And Sales Area

Table 35: B. Braun Melsungen. Products Portfolio

Table 36: Koninklijke Philips Basic Information And Sales Area

Table 37: Koninklijke Philips. Products Portfolio

Table 38: Boston Scientific Basic Information And Sales Area

Table 39: Boston Scientific. Products Portfolio

Table 40: Opto Circuits (India) Basic Information And Sales Area

Table 41: Opto Circuits (India). Products Portfolio

Table 42: Acotec Scientific Basic Information And Sales Area

Table 43: Acotec Scientific. Products Portfolio

Table 44: AR Baltic Medical Basic Information And Sales Area

Table 45: AR Baltic Medical. Products Portfolio

Table 46: Acrostak Basic Information And Sales Area

Table 47: Acrostak. Products Portfolio

Table 48: Biosensors International Group Basic Information And Sales Area

Table 49: Biosensors International Group. Products Portfolio

Table 50: BioMed Basic Information And Sales Area

Table 51: BioMed. Products Portfolio

Table 52: Concept Medical Basic Information And Sales Area

Table 53: Concept Medical. Products Portfolio

Table 54: Cardionovum Basic Information And Sales Area

Table 55: Cardionovum. Products Portfolio

Table 56: Endocor Basic Information And Sales Area

Table 57: Endocor. Products Portfolio

Table 58: Hexacath Sverige Basic Information And Sales Area

Table 59: Hexacath Sverige. Products Portfolio

Table 60: iVascular SLU Basic Information And Sales Area

Table 61: iVascular SLU. Products Portfolio

Table 62: Minvasys Basic Information And Sales Area

Table 63: Minvasys. Products Portfolio

Table 64: MedAlliance Basic Information And Sales Area

Table 65: MedAlliance. Products Portfolio

Table 66: QT Vascular Basic Information And Sales Area

Table 67: QT Vascular. Products Portfolio

Table 68: RD Global-Invamed Basic Information And Sales Area

Table 69: RD Global-Invamed. Products Portfolio

Table 70: SurModics Basic Information And Sales Area

Table 71: SurModics. Products Portfolio

Table 72: Terumo Basic Information And Sales Area

Table 73: Terumo. Products Portfolio

Table 74: Wellinq Basic Information And Sales Area

Table 75: Wellinq. Products Portfolio

Table 76: Global Market Value (USD Million) (2025-2032) By Application

Table 77: Global Market Share (%) By Application (2032)

Table 78: Global Market Value (USD Million) (2025-2032) By Types

Table 79: Global Market Share (%) By Types (2032)

Table 80: Global Drug-Coated Balloons Market Value (USD Million) By Region

Table 81: Global Drug-Coated Balloons Market Share (%) By Region (2025-2032)

Table 82: North America Market Value (USD Million) (2025-2032) By Country

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: North America Market Value (USD Million) (2025-2032) By Types

Table 85: Europe Market Value (USD Million) (2025-2032) By Country

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Europe Market Value (USD Million) (2025-2032) By Types

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 91: South America Market Value (USD Million) (2025-2032) By Country

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: South America Market Value (USD Million) (2025-2032) By Types

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Drug-Coated Balloons Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	7.13 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; B. Braun Melsungen; Koninklijke Philips; Boston Scientific; Opto Circuits (India); Acotec Scientific; AR Baltic Medical; Acrostak; Biosensors International Group; BioMed; Concept Medical; Cardionovum; Endocor; Hexacath Sverige; iVascular SLU; Minvasys; MedAlliance; QT Vascular; RD Global-Invamed; SurModics; Terumo; Wellinq
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in balloon technology, such as improved drug coating and delivery mechanisms, are enhancing the efficacy and safety of Drug-Coated Balloons, contributing to their growing adoption

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Drug-Coated Balloons market, which may hinder market growth

The Drug-Coated Balloons market is experiencing pricing pressure due to competition from alternative treatment options, such as bare-metal stents and angioplasty, which may impact revenue growth

Opportunities2 items

The development of Drug-Coated Balloons for new indications, such as coronary artery disease, is expected to further drive market growth and expand the patient base

Challenges2 items

The Drug-Coated Balloons market is experiencing challenges related to device trackability and reimbursement, which may impact adoption rates and revenue growth

The lack of standardization in Drug-Coated Balloons design and manufacturing processes may lead to variability in product quality, affecting patient outcomes and market credibility

Market Segmentation

Loading chart…

Drug-Coated Balloons Segmentation Breakdown8 items

Application

Hospitals

Cardiac Catheterization Labs

ASCs

Types

DCB for Peripheral Artery Disease

DCB for Coronary Artery Disease

DCB for Other Indications

Regional Insights

Loading chart…

Regional Drivers4 items

Asia Pacific: increasing adoption, favorable policies and investments, growing demographics

North America: high ecosystem maturity, widespread adoption, strong infrastructure

Europe: favorable policies and investments, high demographics, well-established infrastructure

Latin America and Middle East & Africa: increasing adoption, growing investments, rapidly growing demographics

Competitive Landscape

Medtronic: regional expansion

BD: premium pricing

B. Braun Melsungen: innovation pipeline

Koninklijke Philips: local manufacturing

Boston Scientific: OEM tie-ups

Opto Circuits (India): vertical integration

Key Drug-Coated Balloons Companies23 items

Medtronic

B. Braun Melsungen

Koninklijke Philips

Boston Scientific

Opto Circuits (India)

Acotec Scientific

AR Baltic Medical

Acrostak

Biosensors International Group

BioMed

Concept Medical

Cardionovum

Endocor

Hexacath Sverige

iVascular SLU

Minvasys

MedAlliance

QT Vascular

RD Global-Invamed

SurModics

Terumo

Wellinq

Market Ecosystem

Raw material/component suppliers — providing essential materials

OEMs / manufacturers — designing and producing Drug-Coated Balloons

Technology providers — developing underlying technologies

System integrators / EPCs — integrating products into medical systems

Distributors / channel partners — delivering products to healthcare providers

Regulators/standards bodies — establishing and enforcing industry standards

End users / buyers — healthcare providers and patients using the products

Recent Industry Insights

Analyst Overview

Table of Contents